Home
>
US Stocks
>
Mimedx Group Inc
Mimedx Group Inc
MDXG

Mimedx Group Inc

$6.9450.04%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
6.64
Today Low/High
6.64 / 6.94
52 Week Low/High
$5.32 / $13.02
P/E ratio
-16.3814
Market Cap
$1.36B

Company Details

MiMedx is an industry leader in utilizing birth tissue as a platform for regenerative medicine, developing and distributing placental tissue allografts with patent-protected, proprietary processes for multiple sectors of healthcare. As a pioneer in placental biologics, the cinoany has both a core business, focused on addressing the needs of patients with acute and chronic non-healing wounds, and a promising late-stage pipeline targeted at decreasing pain and improving function for patients with degenerative musculoskeletal conditions. The company derives its products from human placental tissues and process these tissues using its proprietary processing methods, including the PURION® process. The company employs Current Good Tissue Practices, Current Good Manufacturing Practices, and terminal sterilization to produce its allografts. MiMedx has supplied over two million allografts, through both direct and consignment shipments.
Organisation
Mimedx Group Inc
Employees
735
Industry
Biotechnology

Discover more

Frequently Asked Questions

What is Mimedx Group Inc share price today

Can Indians buy Mimedx Group Inc shares?

How can I buy Mimedx Group Inc shares from India?

Can Fractional shares of Mimedx Group Inc be purchased?

What are the documents required to start investing in Mimedx Group Inc stocks?

We are a SEBI registered investement advisor